Preanalytics in dementia diagnostics

Identifying external influencing factors, optimising workflows

The analysis of biomarkers in CSF has in recent years become an important component of Alzheimer's disease diagnostics. In particular, beta-amyloids in CSF are considered excellent biomarkers for amyloid pathology, and their relevance is emphasised in diagnostic guidelines.

Beta-amyloids are, however, subject to preanalytical influences. To understand and recognise these is essential since only careful realisation of each work step from lumbar puncture to CSF analysis can ensure high-quality and thus reliable analysis results.

In the last two decades intensive research has resulted in considerable advances in the understanding of preanalytical impact factors, and the number of published research papers is growing rapidly.

 

This brochure serves as a compendium for clinicians and laboratory doctors, providing an overview of the current status of preanalytics in Alzheimer's diagnostics. In a white paper, Hugo Vanderstichele, a renowned scientist in the Alzheimer's biomarker community, explains the advances made in recent years that have contributed to a more comparable measurement of Alzheimer's biomarkers today.

Download now:

Brochure     Whitepaper

By the way: EUROIMMUN not only fully supports you in the field of Alzheimer's diagnostics, EUROIMMUN is YOUR partner when it comes to neurobiomarkers! Discover our research work, our spectrum of analysis parameters and our all-round solutions for the diagnostics of neurological diseases:

Discover now

Back to top
Contact person on site
Please click on a country or enter yours
North America
South & Central America
Europe
Asia
Oceania
Middle East & Africa